This study investigated whether peripheral nerve damage in patients with leprosy impairs local cellular immune responses, thereby reducing wound healing and leading to chronic skin ulceration. Anesthetic and contralateral sensitive skin sites in 42 patients with leprosy were compared for delayed-type hypersensitivity responses to purified protein derivative (PPD) of tuberculin. Leukocyte recruitment, epidermal activation, keratinocyte proliferation, and rates of wound healing after skin biopsy were compared. No significant differences in PPD-induced induration, epidermal activation and thickening or numbers of total T cells, CD8 + T cells, CD1a + Langerhans cells, and proliferating Ki67 + keratinocytes were observed between anesthetic and sensitive skin sites. Similarly, rates of wound healing over 5 days after skin biopsy did not differ significantly. Thus, local leprosy-associated anesthesia does not appear to contribute to local immune compromise or impaired wound healing. Rather, chronic cutaneous ulceration in leprosy most likely results from repeated trauma associated with loss of sensation.
It is not known whether ulceration is due solely to repeated mechanical stress at anesthetic sites or also due to decreased cellular immune response and impaired granulation and tissue repair (wound healing). Improved healing of plantar foot ulcers in patients with foot orthoses supports the hypothesis that ulceration is due to repeated mechanical stress [2, 3] . The alternative hypothesis that nerve damage may lead to an impairment of cellular immune responses is supported by the observation of decreased inflammation at sites of peripheral denervation in experimental arthritis [4] . Similarly, in humans, unilateral paresis in patients with poliomyelitis results in an impaired delayed-type hypersensitivity (DTH) response on the paretic side [5] , and patients with rheumatoid arthritis with preexisting central or peripheral motor nerve lesions do not develop joint inflammation in the paralyzed limb [6, 7] .
To test whether leprosy-induced nerve damage affects local cellular immune responses, patients with leprosy were tested for their in situ responses to a recall antigen (purified protein derivative [PPD] of tuberculin), injected both into an anesthetic skin site and into a contralateral skin site with intact sensation. In addition, the rate of wound healing after skin biopsy sampling at each site was compared.
Materials and Methods

Subjects. Patients with leprosy (
) were recruited to the n p 42 study from the outpatient and inpatient clinics of the All-Africa Leprosy Rehabilitation and Training Center in Addis Ababa, Ethiopia. A subset of patients ( ) agreed to have 4-mm punch n p 17 skin biopsy samples taken from 2 skin sites.
Tuberculin skin test. Sensation to light touch with cotton wool was used to identify an anesthetic skin site on 1 forearm and a sensitive site at a similar location on the contralateral arm of each patient with leprosy. At each selected skin site, 0.1 mL of tuberculin PPD (RT 23; Statens Serum Institut) was administered intradermally. A positive skin test response was denoted by an induration diameter у5 mm after 48 h. Punch biopsy of skin. Patients had biopsy samples taken 72 h after tuberculin skin testing. Lidocaine (Abbott) was injected into the site, and a 4-mm biopsy sample was obtained by biopsy punch (Baker). Biopsy specimens were placed in buffered formalin and embedded in paraffin. Longitudinal skin biopsy sections were placed on positively charged microscope slides for subsequent immunohistologic and histologic staining with hematoxylin-eosin (H-E).
Immunohistology. Paraffin-embedded skin biopsy sections were deparaffinized and rehydrated through graded alcohol. Antigen unmasking was done by boiling slides in 10 mM citric acid buffer (pH 6.0) for 20 min. Immunohistologic staining was performed in an automated immunostainer (Ventana Medical System) with monoclonal antibodies directed against the human T cell markers CD3 (1:1; Ventana Medical System) [8] and CD8 (1:20; Dako), the proliferation marker Ki67 (1:1; Ventana Medical Sys- tem), and the Langerhans cell marker CD1a (1:1; Beckman Coulter) [9] .
Microscopic examination. We assessed the PPD-induced DTH response by using H-E-stained skin biopsy sections. The extent of cellular infiltration in the dermis was evaluated by 2 independent investigators who were unaware of the origin of the biopsy specimens. The extent of cellular infiltration was expressed as a percentage of the dermis occupied by inflammatory cells. A semiquantitative scale was used to evaluate epidermal activation and thickening [9] . Spongiosis (edema) between keratinocytes in the epidermis and the elongation of epidermal ridges indicated epidermal activation. The extent of epidermal thickening and spongiosis was expressed as the DTH microscopic score and was given a value between 0 and 4, with 4 indicating the highest level of epidermal activation and thickening and 0 indicating none. The number and distribution of CD3 ϩ and CD8 ϩ T cells were assessed in all sections. Anti-Ki67 nuclear antigen stains the nuclei of proliferating cells. Ki67 ϩ keratinocytes and CD1a ϩ Langerhans cells were counted and expressed as the number of cells per high-power field (ϫ40 objective) of the epidermis, as described elsewhere [10] . Micrographs were made with a Nikon Microphot-FX.
Wound healing. Biopsy sites were assessed at postbiopsy days 1, 3, and 5. Differences in the drying of the wound, rounding at the wound edge, and the formation of granulation tissue were expressed qualitatively [9] .
Statistical analysis. Nonparametric data were analyzed by using the Wilcoxon signed-rank test for paired samples. was P ! .05 considered to be statistically significant.
Results
Patient characteristics.
In total, 42 patients with leprosy were enrolled into this study: 9 females and 33 males (table 1) with a median age of 26 years (range, 14-57 years). Of the patients, 18 were paucibacillary (all classified as having borderline tuberculoid leprosy, by the Ridley and Jopling classification) [11] , 23 were multibacillary (classified as having lepromatous leprosy and borderline lepromatous leprosy), and 1 was indeterminate. The majority (98%) had been diagnosed with a reactional episode (reversal reaction, erythema nodosum leprosum, or neuritis) at some time prior to the study (table 1) . Of the 42 patients, 10 were newly referred to the clinic and not yet treated, 21 were receiving multidrug therapy (MDT) with prednisolone, and 11 had completed MDT and were receiving prednisolone or prednisolone plus thalidomide (1 patient).
Skin induration in response to PPD. Of the 42 patients, 17 showed у1 positive skin test response to PPD administration (table 1) . Prednisolone is often used for treatment of leprosy reactions and neuritis and may depress T cell responses [12] . However, in the present study, the drug had no significant effect on the induration at either anesthetic or sensitive sites (data not shown). There was no significant difference between the diameters of induration at the PPD injection sites in anesthetic versus sensitive skin in these patients with leprosy (table 1 and  table 2) .
Histology of DTH response to PPD in the epidermis. Permission for punch biopsies from the sites of PPD administration was obtained for 7 of the 17 skin test-positive and 10 of the 25 skin test-negative patients. H-E-stained skin sections were examined to assess DTH responses by using the DTH microscopic score (see Materials and Methods). We noted that, in biopsy specimens from 7 of the 10 patients who had not displayed induration (skin test negative), there was almost no change from baseline epidermal histology. Patients who were skin test positive displayed epidermal activation and thickening (figure 1). The DTH microscopic score correlated with the extent of induration ( , Pearson correlation test for DTH P p .008 responses in anesthetic skin;
, Pearson correlation test P p .035 for DTH responses in sensitive skin). However the DTH microscopic score did not correlate with presence or absence of anesthesia at the skin site tested (table 2) .
Cell composition with dermis at PPD injection site. The extent of cellular infiltration (area of dermis filled with cells) in the PPD injection site was evaluated by 2 independent investigators who were unaware of the nature of the biopsy specimen. No difference in the distribution of extent of cellularity was noted between anesthetic and sensitive sites (figure 2A). One patient with borderline leprosy (patient 28; table 1) had extensive infiltration (∼50% of the dermis occupied by cells) of the negative PPD site. The other PPD-negative biopsy specimens showed involvement of 3.5%-20% of the dermis, suggesting that the underlying leprosy disease was of variable cellularity at that particular site.
In patients with a positive PPD response, a mononuclear cell infiltrate occupying 110% of the dermis was clearly evident. Of interest, in the PPD-positive biopsy specimens, there was a cor- relation between the extent of induration in response to PPD and the percent of dermis infiltrated (figure 2B). However, the area of the dermis occupied by the cellular infiltrate was not related to whether that site was anesthetic or sensitive (figure 1A and 1E and figure 2B ).
Immunohistology was used to identify T cells (CD3 ϩ and CD8 ϩ ) in the dermis and Langerhans cells (CD1a ϩ cells) and Ki67 ϩ proliferating keratinocytes in the epidermis in each biopsy specimen. Some variation in the number and distribution of CD3 ϩ and CD8 ϩ cells in the dermis was observed among patients-probably due to the underlying leprosy disease. Nevertheless, in the same patient, the extent of cellularity and the cellular distribution were similar in sections obtained from either anesthetic or sensitive skin sites (figure 1). Numbers of Ki67 ϩ keratinocytes (anesthetic site: median, 0.3 keratinocytes; range, 0-0.6 keratinocytes; sensitive site: median, 0.2 keratinocytes; range, 0-0.3 keratinocytes;
) and CD1a ϩ Lan-P p .65 gerhans cells (anesthetic site: median, 6 Langerhans cells; range, 1-11 Langerhans cells; sensitive site: median, 5 Langerhans cells; range, 0.5-6 Langerhans cells;
) located in the P p .60 epidermis overlying the DTH site were also similar whether in the presence or absence of anesthesia ( figure 1) .
Wound healing. The healing of the wound produced by the 4-mm punch biopsy was assessed 1, 3, and 5 days after biopsy.
By 24 h after biopsy, the PPD-injected sites were dry, lacked bleeding points, and were covered with a whitish film. By 3 days, the edge of the wound, which originally had a sharp vertical wall, started to curve, and the wound became shallower. By 5 days, the epidermis started closing the wound. Similar rates of drying of the wound, rounding of the wound bed, and shrinking of the biopsy site were noted for anesthetic and sensitive sites, indicating no discernable difference in the rate of wound healing. This was noted for each patient and for the group as a whole.
Discussion
We examined whether nerve damage in leprosy is associated with impaired cellular immunity and/or delayed wound healing by determining reactivity to PPD and monitoring healing after biopsy of the site. A detailed examination of PPD reactivity and of immune cell composition and epidermal activation at the DTH site failed to demonstrate differences between anesthetic and sensitive skin sites in patients with leprosy. This strongly suggests that nerve damage in leprosy is not associated with decreased cell trafficking into the site of a cellular immune response to soluble antigen. Since there was no impairment of cellular response in the skin, this does not appear to be a cause for the chronic ulcers of leprosy.
Of interest, only 40% of the patients with leprosy in this study had a PPD-induced skin induration 15 mm. The lack of a PPD response in the majority of patients was surprising in a population with a high frequency of exposure to tuberculosis. Corticosteroid treatment did not appear to be the explanation for the low PPD responsiveness in this study group. Anergy to PPD in patients with leprosy has been reported elsewhere and may be due to M. leprae-induced cross-reactive T cell anergy [13, 14] . Alternatively, in those persons vaccinated with bacille Calmette-Guérin (BCG) at birth, BCG-induced tuberculin sensitivity may have declined with age, as has been shown to occur in the Karonga District of Malawi [15] . It has been suggested that a decrease in tuberculin sensitivity may be attributed partly to the effect of exposure to environmental mycobacteria [16] .
Microscopic evaluation of the cellular response to PPD did not reveal any significant differences in anesthetic or sensitive sites within each person; however, differences were observed between positive PPD and negative PPD sites. For example, as reported elsewhere, an increase in the dermal accumulation of monocytes and T cells and epidermal thickening were observed in the PPD-responsive sites [17] . In addition, a clear increase in CD1a ϩ Langerhans cells and Ki67 ϩ proliferating keratinocytes was noted in PPD-positive sites, compared with PPD-negative sites. This observation confirms earlier studies in which keratinocytes were found to proliferate and CD1a ϩ Langerhans cells were observed to accumulate in the skin of patients with leprosy in response to PPD and in response to intradermal administration of granulocyte monocyte colony-stimulating factor (GM-CSF) [9, 10, 17, 18] . Similar rates of wound healing were noted at the anesthetic and the sensitive skin sites. This observation suggested that not only were similar cell populations recruited to the wound bed but also that those soluble mediators required to induce wound healing were produced by cells in both anesthetic and sensitive skin. In previous studies, we showed that activated peripheral blood mononuclear cells produce factors that modify keratinocyte growth and differentiation. Among these factors are interleukin-3 and GM-CSF, which stimulate keratinocyte growth [19] . We have also shown that intradermal administration of recombinant GM-CSF to patients with leprosy leads to increased thickness of the epidermis and activation of keratinocyte proliferation, as indicated by increased expression of Ki67 ϩ nuclear antigen [9, 10] . Thus, leukocyte and keratinocyte activation and cytokine production including GM-CSF are probably intact in leprosy-affected skin, even in the presence of nerve damage.
In conclusion, our study results indicate that the local nerve damage associated with M. leprae infection does not appear to adversely affect DTH responses to the recall antigen PPD or to inhibit local tissue repair. Therefore, the presence of chronic ulcers in patients with leprosy is likely due to continuing trauma at an anesthetic site, to secondary infections, or both rather than to inadequate cellular trafficking and immune responsiveness.
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